141 related articles for article (PubMed ID: 11144027)
41. Bone cells required for osteoclastic resorption but not for osteoclastic differentiation.
Owens JM; Gallagher AC; Chambers TJ
Biochem Biophys Res Commun; 1996 May; 222(2):225-9. PubMed ID: 8670187
[TBL] [Abstract][Full Text] [Related]
42. Prostaglandin E2 stimulates osteoclast-like cell formation and bone-resorbing activity via osteoblasts: role of cAMP-dependent protein kinase.
Kaji H; Sugimoto T; Kanatani M; Fukase M; Kumegawa M; Chihara K
J Bone Miner Res; 1996 Jan; 11(1):62-71. PubMed ID: 8770698
[TBL] [Abstract][Full Text] [Related]
43. Intercellular adhesion molecule 1 discriminates functionally different populations of human osteoblasts: characteristic involvement of cell cycle regulators.
Tanaka Y; Maruo A; Fujii K; Nomi M; Nakamura T; Eto S; Minami Y
J Bone Miner Res; 2000 Oct; 15(10):1912-23. PubMed ID: 11028443
[TBL] [Abstract][Full Text] [Related]
44. Osteoblastic control of osteoclast bone resorption in a serum-free co-culture system. Lack of effect of parathyroid hormone.
Teti A; Grano M; Colucci S; Zambonin Zallone A
J Endocrinol Invest; 1992; 15(9 Suppl 6):63-8. PubMed ID: 1300341
[No Abstract] [Full Text] [Related]
45. Isolation of a human homolog of osteoclast inhibitory lectin that inhibits the formation and function of osteoclasts.
Hu YS; Zhou H; Myers D; Quinn JM; Atkins GJ; Ly C; Gange C; Kartsogiannis V; Elliott J; Kostakis P; Zannettino AC; Cromer B; McKinstry WJ; Findlay DM; Gillespie MT; Ng KW
J Bone Miner Res; 2004 Jan; 19(1):89-99. PubMed ID: 14753741
[TBL] [Abstract][Full Text] [Related]
46. Inhibitory effect of ipriflavone on osteoclast-mediated bone resorption and new osteoclast formation in long-term cultures of mouse unfractionated bone cells.
Notoya K; Yoshida K; Taketomi S; Yamazaki I; Kumegawa M
Calcif Tissue Int; 1993 Sep; 53(3):206-9. PubMed ID: 8242474
[TBL] [Abstract][Full Text] [Related]
47. Regulation of bone resorption and osteoclast survival by nitric oxide: possible involvement of NMDA-receptor.
Mentaverri R; Kamel S; Wattel A; Prouillet C; Sevenet N; Petit JP; Tordjmann T; Brazier M
J Cell Biochem; 2003 Apr; 88(6):1145-56. PubMed ID: 12647297
[TBL] [Abstract][Full Text] [Related]
48. Thiazolidinediones inhibit osteoclast-like cell formation and bone resorption in vitro.
Okazaki R; Toriumi M; Fukumoto S; Miyamoto M; Fujita T; Tanaka K; Takeuchi Y
Endocrinology; 1999 Nov; 140(11):5060-5. PubMed ID: 10537132
[TBL] [Abstract][Full Text] [Related]
49. The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures.
Romas E; Udagawa N; Zhou H; Tamura T; Saito M; Taga T; Hilton DJ; Suda T; Ng KW; Martin TJ
J Exp Med; 1996 Jun; 183(6):2581-91. PubMed ID: 8676079
[TBL] [Abstract][Full Text] [Related]
50. Ipriflavone inhibits murine osteoclast formation in vitro.
Morita I; Sakaguchi K; Kurachi T; Murota S
Calcif Tissue Int; 1992; 51 Suppl 1():S7-10. PubMed ID: 1422984
[TBL] [Abstract][Full Text] [Related]
51. Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms.
O'Sullivan S; Naot D; Callon K; Porteous F; Horne A; Wattie D; Watson M; Cornish J; Browett P; Grey A
J Bone Miner Res; 2007 Nov; 22(11):1679-89. PubMed ID: 17663639
[TBL] [Abstract][Full Text] [Related]
52. Tumor necrosis factor-alpha cooperates with receptor activator of nuclear factor kappaB ligand in generation of osteoclasts in stromal cell-depleted rat bone marrow cell culture.
Komine M; Kukita A; Kukita T; Ogata Y; Hotokebuchi T; Kohashi O
Bone; 2001 May; 28(5):474-83. PubMed ID: 11344046
[TBL] [Abstract][Full Text] [Related]
53. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.
Udagawa N; Takahashi N; Yasuda H; Mizuno A; Itoh K; Ueno Y; Shinki T; Gillespie MT; Martin TJ; Higashio K; Suda T
Endocrinology; 2000 Sep; 141(9):3478-84. PubMed ID: 10965921
[TBL] [Abstract][Full Text] [Related]
54. Mouse osteoblastic cells (MC3T3-E1) at different stages of differentiation have opposite effects on osteoclastic cell formation.
Hiura K; Sumitani K; Kawata T; Higashino K; Okawa M; Sato T; Hakeda Y; Kumegawa M
Endocrinology; 1991 Mar; 128(3):1630-7. PubMed ID: 1999177
[TBL] [Abstract][Full Text] [Related]
55. Vitamin K2 inhibits osteoclastic bone resorption by inducing osteoclast apoptosis.
Kameda T; Miyazawa K; Mori Y; Yuasa T; Shiokawa M; Nakamaru Y; Mano H; Hakeda Y; Kameda A; Kumegawa M
Biochem Biophys Res Commun; 1996 Mar; 220(3):515-9. PubMed ID: 8607797
[TBL] [Abstract][Full Text] [Related]
56. Osteoblastic cells are involved in osteoclast formation.
Takahashi N; Akatsu T; Udagawa N; Sasaki T; Yamaguchi A; Moseley JM; Martin TJ; Suda T
Endocrinology; 1988 Nov; 123(5):2600-2. PubMed ID: 2844518
[TBL] [Abstract][Full Text] [Related]
57. MLO-Y4 osteocyte-like cells support osteoclast formation and activation.
Zhao S; Zhang YK; Harris S; Ahuja SS; Bonewald LF
J Bone Miner Res; 2002 Nov; 17(11):2068-79. PubMed ID: 12412815
[TBL] [Abstract][Full Text] [Related]
58. The regulation of osteoclastic development and function.
Chambers TJ
Ciba Found Symp; 1988; 136():92-107. PubMed ID: 3068019
[TBL] [Abstract][Full Text] [Related]
59. Role of 1 alpha,25-dihydroxyvitamin D3 in osteoclast differentiation and function.
Suda T; Jimi E; Nakamura I; Takahashi N
Methods Enzymol; 1997; 282():223-35. PubMed ID: 9330291
[No Abstract] [Full Text] [Related]
60. Cloning of an osteoblastic cell line involved in the formation of osteoclast-like cells.
Yamashita T; Asano K; Takahashi N; Akatsu T; Udagawa N; Sasaki T; Martin TJ; Suda T
J Cell Physiol; 1990 Dec; 145(3):587-95. PubMed ID: 1703173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]